LIPOPOLYSACCHARIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF FETAL MALFORMATIONS

The present invention refers to lipopolysaccharides, characterized in that they are agonist of both Toll-like Receptors TLR2 and TLR4, for use in the prevention and/or treatment of fetal malformations, preferably fetal malformations caused by malformations of muscle connective tissue such as Congeni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LLAMAS MATÍAS, Miguel Angel, VALLEJO CREMADES, María Teresa, FRESNO ESCUDERO, Manuel
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LLAMAS MATÍAS, Miguel Angel
VALLEJO CREMADES, María Teresa
FRESNO ESCUDERO, Manuel
description The present invention refers to lipopolysaccharides, characterized in that they are agonist of both Toll-like Receptors TLR2 and TLR4, for use in the prevention and/or treatment of fetal malformations, preferably fetal malformations caused by malformations of muscle connective tissue such as Congenital diaphragmatic hernia (CDH).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4295855A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4295855A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4295855A13</originalsourceid><addsrcrecordid>eNrjZAjx8QzwD_D3iQx2dHb2cAzydHFVcPMPUggNdlXw9FMI8XBVCAhyDXP1C_H091Nw9HPRB0qGBLk6hvgCxRT83RTcXEMcfRR8HX2A2nwdQcqCeRhY0xJzilN5oTQ3A0iVs4duakF-fGpxQWJyal5qSbxrgImRpamFqamjoTERSgDoGS_4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LIPOPOLYSACCHARIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF FETAL MALFORMATIONS</title><source>esp@cenet</source><creator>LLAMAS MATÍAS, Miguel Angel ; VALLEJO CREMADES, María Teresa ; FRESNO ESCUDERO, Manuel</creator><creatorcontrib>LLAMAS MATÍAS, Miguel Angel ; VALLEJO CREMADES, María Teresa ; FRESNO ESCUDERO, Manuel</creatorcontrib><description>The present invention refers to lipopolysaccharides, characterized in that they are agonist of both Toll-like Receptors TLR2 and TLR4, for use in the prevention and/or treatment of fetal malformations, preferably fetal malformations caused by malformations of muscle connective tissue such as Congenital diaphragmatic hernia (CDH).</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231227&amp;DB=EPODOC&amp;CC=EP&amp;NR=4295855A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231227&amp;DB=EPODOC&amp;CC=EP&amp;NR=4295855A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LLAMAS MATÍAS, Miguel Angel</creatorcontrib><creatorcontrib>VALLEJO CREMADES, María Teresa</creatorcontrib><creatorcontrib>FRESNO ESCUDERO, Manuel</creatorcontrib><title>LIPOPOLYSACCHARIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF FETAL MALFORMATIONS</title><description>The present invention refers to lipopolysaccharides, characterized in that they are agonist of both Toll-like Receptors TLR2 and TLR4, for use in the prevention and/or treatment of fetal malformations, preferably fetal malformations caused by malformations of muscle connective tissue such as Congenital diaphragmatic hernia (CDH).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAjx8QzwD_D3iQx2dHb2cAzydHFVcPMPUggNdlXw9FMI8XBVCAhyDXP1C_H091Nw9HPRB0qGBLk6hvgCxRT83RTcXEMcfRR8HX2A2nwdQcqCeRhY0xJzilN5oTQ3A0iVs4duakF-fGpxQWJyal5qSbxrgImRpamFqamjoTERSgDoGS_4</recordid><startdate>20231227</startdate><enddate>20231227</enddate><creator>LLAMAS MATÍAS, Miguel Angel</creator><creator>VALLEJO CREMADES, María Teresa</creator><creator>FRESNO ESCUDERO, Manuel</creator><scope>EVB</scope></search><sort><creationdate>20231227</creationdate><title>LIPOPOLYSACCHARIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF FETAL MALFORMATIONS</title><author>LLAMAS MATÍAS, Miguel Angel ; VALLEJO CREMADES, María Teresa ; FRESNO ESCUDERO, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4295855A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LLAMAS MATÍAS, Miguel Angel</creatorcontrib><creatorcontrib>VALLEJO CREMADES, María Teresa</creatorcontrib><creatorcontrib>FRESNO ESCUDERO, Manuel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LLAMAS MATÍAS, Miguel Angel</au><au>VALLEJO CREMADES, María Teresa</au><au>FRESNO ESCUDERO, Manuel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LIPOPOLYSACCHARIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF FETAL MALFORMATIONS</title><date>2023-12-27</date><risdate>2023</risdate><abstract>The present invention refers to lipopolysaccharides, characterized in that they are agonist of both Toll-like Receptors TLR2 and TLR4, for use in the prevention and/or treatment of fetal malformations, preferably fetal malformations caused by malformations of muscle connective tissue such as Congenital diaphragmatic hernia (CDH).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4295855A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title LIPOPOLYSACCHARIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF FETAL MALFORMATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T13%3A52%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LLAMAS%20MAT%C3%8DAS,%20Miguel%20Angel&rft.date=2023-12-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4295855A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true